Real-world reasons and outcomes for 1-month versus longer dual antiplatelet therapy strategies with a polymer-free BIOLIMUS A9-coated stent.
Guglielmo GalloneFabrizio D'AscenzoGiacomo BoccuzziBernardo CorteseMaurizio Di BiasiPierluigi OmedèDavide CapodannoEnrico CerratoPaolo VicinelliVincenzo InfantinoArnaldo PoliFabrizio UgoFederico ConrottoGiulietta GrigisFerdinando VarbellaRoberto A LatiniMaurizio D'UrbanoAndrea MontaboneGaetano SenatoreErika FerraraMaurizio D'AmicoGaetano M De FerrariAlfonso IelasiPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
In a large all-comers registry of PF-BES PCI, no interaction of planned DAPT strategy (1-month vs. >1-month) with outcomes was found. This observation warrants investigation in adequately powered randomized studies (ClinicalTrials.gov NCT03622203).
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- acute coronary syndrome
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- double blind
- coronary artery bypass grafting
- placebo controlled
- heart failure
- adipose tissue
- atrial fibrillation
- glycemic control